Impact of Albumin Assays in the Diagnosis of Malnutrition in Hemodialysis Patients: A Cohort Study

J Ren Nutr. 2023 Mar;33(2):332-336. doi: 10.1053/j.jrn.2022.10.001. Epub 2022 Oct 19.

Abstract

Objective: In hemodialysis (HD) patients, malnutrition should be diagnosed by several assessment tools including a plasma albumin concentration of less than 3.8 g/dL or 3.5 g/dL using bromocresol green or immunonephelometry (IN), respectively. However, albumin measurement is not yet standardized and two alternative methods are also commonly used in laboratories: bromocresol purple (BCP) and immunoturbidimetry (IT). This study aimed to revisit the hypoalbuminemia thresholds for BCP and IT, in HD patients.

Methods: Plasma albumin was measured by the four analytical methods during the monthly HD nutritional assessment of 103 prospectively included patients.

Results: Significant differences in albumin levels were observed in HD patients depending on the method used. Using BCP or IT with the cut-off at 3.5 g/dL (determined for the general population) we obtained 33% and 9.7% of false hypoalbuminemia in comparison to IN (mean bias of -0.4 g/dL and -0.065 g/dL, respectively). The best hypoalbuminemia threshold for BCP was 3.05 g/dL and 3.4 g/dL for IT. Twenty percent of HD patients were classified as malnourished when albumin was determined by IN. Similar rates were obtained using the new hypoalbuminemia cut-offs for BCP (18.5%) and IT (19.5%).

Conclusion: To avoid nutritional misclassification of HD patients, we should adjust hypoalbuminemia thresholds when BCP or IT methods are used in laboratories.

Keywords: Albumin; analytical method; cut-off; hemodialysis; malnutrition.

MeSH terms

  • Bromcresol Purple
  • Cohort Studies
  • Humans
  • Malnutrition* / diagnosis
  • Renal Dialysis* / adverse effects
  • Serum Albumin

Substances

  • Serum Albumin
  • Bromcresol Purple